Adjupanrix, a pandemic influenza vaccine (split virion, inactivated, adjuvanted) manufactured by GSK, has been reserved for future manufacturing and supply under a framework agreement with the European Commission’s (EC) Health Emergency Preparedness and Response Authority (HERA). Influenza pandemics, which are caused by a novel strain of influenza to which the general population has little to no […]

The post 85mn Pandemic Flu Vaccines To Be Supplied By GSK To Europe first appeared on World Pharma Today.